The Ciprofloxacin hydrochloride tablets passed the unannounced on-site inspection about Evaluation of quality and efficacy of generic drugs.
SendTime : 2021-12-14 |
In January 2020, the registration application for consistency evaluation of Ciprofloxacin Hydrochloride tablets was accepted. On January 5, 2021, the company obtained the Approval Notice of Supplementary Application for Drugs issued by the State Medical Products Administration, and approved the drug to pass the consistency evaluation of generic drug quality and efficacy. As the fourth Domestic company, the company obtained the shortlisting qualification of national centralized procurement.
?
-
2021-12-14
-
2021-12-14
-
2021-12-14
-
2015-03-10